PMID: 1417131Sep 1, 1992Paper

Clinical significance of rheumatoid factors in early rheumatoid arthritis: results of a follow up study

Annals of the Rheumatic Diseases
D van ZebenF C Breedveld


Serum rheumatoid factors (RF) were measured yearly in 135 women with rheumatoid arthritis by the Waaler-Rose and latex fixation tests and IgM, IgA, and IgG RF were measured by enzyme linked immunosorbent assays (ELISAs). The patients were followed up from an early phase of the disease for a mean duration of six years. Patients with a persistently positive RF test, irrespective of the type of test used, had more radiological abnormalities, more disease activity, worse functional ability, more extra-articular manifestations, and needed more treatment with second line drugs than patients with persistently negative or variably positive and negative test results during the follow up. Increased RF levels, especially a high level of IgA RF within three years of the onset of symptoms, was prognostic for a more severe disease outcome six years after the onset of symptoms.


Jan 1, 1979·Journal of Clinical Pathology·F KleinJ M Singer
May 22, 1976·British Medical Journal·A FlemingM Corbett
Jan 1, 1990·Rheumatology International·F EggelmeijerF C Breedveld
Jan 1, 1988·Scandinavian Journal of Rheumatology. Supplement·H Winska WilochF Hay
Jan 1, 1988·Scandinavian Journal of Rheumatology. Supplement·T MöttönenM Oka
May 1, 1987·Annals of the Rheumatic Diseases·J A ArnasonH Valdimarsson
Jan 1, 1987·Annals of the Rheumatic Diseases·M Gioud-PaquetJ C Monier
Mar 1, 1986·Annals of the Rheumatic Diseases·R M PopeE Nunnery
Jan 1, 1985·Rheumatology International·M L WestedtJ Lindeman
Jan 1, 1971·Headache·L Weissman
Sep 1, 1984·Clinical Rheumatology·C E SiegertA Cats
Oct 1, 1984·Annals of the Rheumatic Diseases·I TeitssonH Valdimarsson
Feb 1, 1980·Arthritis and Rheumatism·J F FriesH R Holman
Dec 1, 1957·Annals of the Rheumatic Diseases·J J DUTHIEM THOMPSON
Nov 16, 1963·British Medical Journal·M H LUNTZJ P LLOYD
May 1, 1964·Annals of the Rheumatic Diseases·J J DUTHIEA J LAWRIE

❮ Previous
Next ❯


Nov 24, 1995·Pharmacy World & Science : PWS·B A t Hart, H G Otten
Feb 7, 2013·Journal of Physiology and Biochemistry·Amit Kumar Shrivastava, Aparna Pandey
Jan 1, 1996·La Revue de médecine interne·B Combe
Dec 1, 1992·Current Opinion in Immunology·P Wordsworth
May 18, 2005·Clinica Chimica Acta; International Journal of Clinical Chemistry·M TampoiaN Pansini
Sep 30, 2009·Nature Reviews. Rheumatology·Dirkjan van Schaardenburg, Ben A C Dijkmans
Jun 18, 2004·The New England Journal of Medicine·Jonathan C W EdwardsTim Shaw
Apr 26, 2007·Annals of the Rheumatic Diseases·M Güler-YükselW F Lems
Jan 1, 1994·Annals of the Rheumatic Diseases·G YanniB Bresnihan
Oct 9, 2003·Annals of the Rheumatic Diseases·T ShawM C Totoritis
Jul 11, 2006·Journal of Clinical Pathology·W S A SmellieT M Reynolds
Mar 14, 2007·Arthritis Research & Therapy·Claudia Mauri, Michael R Ehrenstein
Jul 23, 2004·Expert Opinion on Investigational Drugs·Joel D Abbott, Larry W Moreland
Oct 9, 2009·Clinical and Experimental Hypertension : CHE·Vasileios F PanoulasGeorge D Kitas
Sep 14, 2007·Annals of Medicine·Marcin OkrojAnna M Blom
Apr 16, 2002·Arthritis and Rheumatism·Alain SarauxPierre Youinou
Jan 24, 2012·Best Practice & Research. Clinical Rheumatology·Dimitrios A PappasJoan M Bathon
Jan 22, 2008·The Journal of Allergy and Clinical Immunology·Marc C Levesque, E William St Clair
Sep 4, 2007·Journal of Clinical Pharmacology·Ferdinand BreedveldBrian E Davies
Jul 11, 2008·Immunological Reviews·Koichi YanabaThomas F Tedder

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibodies: Agglutination

Antibody-mediated agglutination is the clumping of cells in the presence of antibody, which binds multiple cells together. This enhances the clearance of pathogens. Find the latest research on antibody-mediated agglutination here.